PERLETTI, G. Reply to: Clarification to provide further understanding of the conduct and design of TROPIC: A Phase 3 trial of cabazitaxel versus mitoxantrone in patients with metastatic castration-resistant prostate cancer. Archivio Italiano di Urologia e Andrologia, v. 88, n. 1, p. 74-75, 31 mar. 2016.